Metastatic breast cancer study day

Tuesday 14 October 2025, 9am to 5pm BST

What to expect

This study day will focus on important new approaches to management of patients with early breast cancer. Topics will include all aspects of the patient pathway including surgery, endocrine, Immune and targeted therapies, radiotherapy and the prevention and management of treatment toxicities.

What to expect

Leaders in their respective fields will present updates on the management of early breast cancer of all major subtypes: HER2+, triple negative and hormone receptor positive. Patient support approaches for fertility preservation, bone health & menopausal symptoms will be discussed in detail. The session will be interactive to facilitate learning.

Last updated: June 2025